
-
'Multiple concussions' force France lock Willemse to retire
-
Athletic 'not afraid' of Arsenal on Champions League return: Inaki Williams
-
Hatton's family speak of 'immeasurable' loss after boxer's death
-
Rubio promises 'unwavering support' for Israel in Gaza goals
-
Stocks diverge ahead of expected US rate cut
-
Alfred out of world 200m with hamstring strain
-
Ex-British soldier goes on trial in landmark Bloody Sunday case
-
Pro-Palestinian protestors invading Vuelta course 'unacceptable': organisers
-
Fruit fly tests in Greece target invasive species threat
-
US 'very close' to TikTok deal with China: US Treasury chief
-
Paolini vows to 'fight until last ball' for BJK Cup glory
-
'Multiple concussions' forces France lock Willemse to retire
-
Rubio talks Gaza with Netanyahu after Qatar strike
-
Pakistan lodge protest as India tensions spill into cricket
-
German defence giant Rheinmetall to take over warship maker
-
Arab, Muslim leaders hold emergency talks after Israel's Qatar attack
-
Markets mixed ahead of expected US rate cut
-
Rubio takes up Qatar strike unease with Netanyahu
-
US-China trade talks resume in Madrid
-
Gaza aid flotilla carrying Greta Thunberg departs Tunisia
-
New Nepal interim ministers sworn in after protests
-
Cluster bombs kill, wound over 1,200 in Ukraine since 2022: monitor
-
Most Asian markets drop ahead of expected US rate cut
-
Australia, Papua New Guinea to sign 'historic' defence deal
-
Myanmar junta says no voting in dozens of constituencies
-
Rubio to discuss Qatar aftermath, Gaza with Netanyahu
-
Chinese factory, consumer activity slow amid economy struggles
-
US cuts leave Zimbabwe sex workers scrambling for alternatives
-
Alonso's Real Madrid revitalised for new Champions League mission
-
Arsenal eye Champions League charge with revamped attack
-
'No regrets': wounded Nepali protesters proud at change
-
Key Emmys moments: Children, Colbert, women and politics
-
'No regrets': wounded Nepalis protesters proud at change
-
'Adolescence,' 'The Studio' dominate television's Emmy Awards
-
WTO fishing deal: the net results
-
Malaysia's largest island state aims to be region's 'green battery'
-
Philippines president says corruption scandal protests justified
-
Asian markets fluctuate ahead of expected US rate cut
-
UK aristocrat, partner face jail over baby daughter's death
-
Japan and Fiji cruise into Pacific Nations Cup rugby final rematch
-
As King Charles hosts Trump, what do UK state visits entail?
-
First-ever Tanzanian gold as Simbu dips past Petros in world marathon
-
100 days later, US federal workers navigate post-Musk wreckage
-
Rising oceans to threaten 1.5 million Australians by 2050: report
-
Kipyegon bids for fourth 1500m world gold, Wanyonyi in loaded 800m
-
'The Studio,' 'Severance' and 'Adolescence' among Emmy winners
-
Trump and King Charles: heads of state with opposing personalities
-
Scheffler surges to PGA Procore victory in Ryder Cup warm-up
-
Bloody Sunday trial of British ex-soldier to open in Belfast
-
Trump heads for historic second UK state visit

Monsanto: object of Bayer desire despite GMO fears
German pharmaceutical giant Bayer sees in agroindustry giant Monsanto a gem worth at least $62 million for its dominant global position selling seeds sought by farmers of corn, soybeans, cotton and other commodity crops.
But for the Green movement, especially in Europe, Monsanto turns stomachs for unstinting promotion of genetically modified crops and its widely used herbicide Roundup, often feared as a possible carcinogen.
The merger is still under discussion -- Monsanto rejected the price as too low on Tuesday, but said it is willing to keep talking.
But it raises questions across an industry that is pushing the frontiers of biochemistry amid great nervousness, and consolidating into just a handful of very powerful firms.
- What is Monsanto? -
St. Louis, Missouri-based Monsanto was established by pharmacist John Queeny in 1901 to produce saccharine. Queeny named the company after his wife Olga Monsanto Queeny.
By the 1940s, the company was producing farm-oriented chemicals, particularly the widely used herbicide 2,4-D, and slowly became a US household name.
Combined with another dangerous chemical, 2,4-D was used to make the notorious Vietnam War-era defoliant Agent Orange.
In 1976, it launched probably its most famous product, Roundup, the world's most widely used herbicide. Its active chemical is glyphosate.
The company began in the 1970s looking at the crops that the herbicides were protected, building cell and molecular biology units. In 1982, its scientists were the first to genetically modify a plant cell.
Monsanto then started buying other seed companies and withing five years began field trials of genetically modified seeds.
It eventually developed soybean, corn, cotton, canola and other crops that were genetically engineered to be tolerant of Roundup.
In 1994, Monsanto also became the first to begin selling the biotechnology-based hormone for dairy cows, rBST and rBGH, which was used across the United States to boost milk production. The two have been banned by many other major dairy producers.
- Why is Monsanto so valuable to Bayer? -
Monsanto is by far the world's leading producer of genetically modified crop seeds, and in many of its seed lines it has a dominant market position.
According to Farm Journal, it had 35.5 percent of the market for corn in the United States in 2014. It had a 28 percent share for soybeans, behind DuPont.
The company owns around 1,700 patents. In 1991, it lost its patent on glyphosate herbicide, but retains a huge market share in part by having marketed its "Roundup-Ready" genetically modified seeds.
Monsanto also owns one of the leading data analytics firms for farmers, Climate Corp.
- What makes Monsanto so controversial? -
Many people and countries, especially in Europe, have not accepted the use of genetically modified organisms -- which they label "frankenfoods."
They say GMO seeds are dangerous to introduce to the farm and food system generally, and foods produced from GMO crops could turn out unsafe to eat.
In addition, Monsanto's strong market position, critics say, can leave farmers dependent on it because they cannot reproduce Monsanto crops with their own seeds due to the company's patents.
In addition, critics say the herbicides the company sells are dangerous to human health, and some have been banned in certain countries.
A merger with Bayer thus could give the combined company even more power in the market, with farmers already facing consolidation among suppliers.
In December, DuPont and Dow Chemical announce plans to merge, and in China National Chemical Corp. or ChemChina, made a $43 billion offer for Syngenta.
P.Martin--AMWN